147 related articles for article (PubMed ID: 26813510)
1. [NF-κB signaling pathways and the future perspectives of bone disease therapy using selective inhibitors of NF-κB].
Jimi E; Fukushima H
Clin Calcium; 2016 Feb; 26(2):298-304. PubMed ID: 26813510
[TBL] [Abstract][Full Text] [Related]
2. The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis.
Soysa NS; Alles N; Weih D; Lovas A; Mian AH; Shimokawa H; Yasuda H; Weih F; Jimi E; Ohya K; Aoki K
J Bone Miner Res; 2010 Apr; 25(4):809-18. PubMed ID: 19839765
[TBL] [Abstract][Full Text] [Related]
3. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
4. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
[TBL] [Abstract][Full Text] [Related]
5. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
[TBL] [Abstract][Full Text] [Related]
7. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
[TBL] [Abstract][Full Text] [Related]
8. Processing of the NF-kappa B2 precursor p100 to p52 is critical for RANKL-induced osteoclast differentiation.
Maruyama T; Fukushima H; Nakao K; Shin M; Yasuda H; Weih F; Doi T; Aoki K; Alles N; Ohya K; Hosokawa R; Jimi E
J Bone Miner Res; 2010 May; 25(5):1058-67. PubMed ID: 19874202
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
11. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
[TBL] [Abstract][Full Text] [Related]
12. The bone anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast mineralization and suppresses osteoclast differentiation by antagonizing NF-κB activation.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2012 Sep; 30(3):708-12. PubMed ID: 22751682
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
[TBL] [Abstract][Full Text] [Related]
14. RelB-induced expression of Cot, an MAP3K family member, rescues RANKL-induced osteoclastogenesis in alymphoplasia mice by promoting NF-κB2 processing by IKKα.
Taniguchi R; Fukushima H; Osawa K; Maruyama T; Yasuda H; Weih F; Doi T; Maki K; Jimi E
J Biol Chem; 2014 Mar; 289(11):7349-61. PubMed ID: 24488495
[TBL] [Abstract][Full Text] [Related]
15. The Role of NF-κB in Physiological Bone Development and Inflammatory Bone Diseases: Is NF-κB Inhibition "Killing Two Birds with One Stone"?
Jimi E; Takakura N; Hiura F; Nakamura I; Hirata-Tsuchiya S
Cells; 2019 Dec; 8(12):. PubMed ID: 31847314
[TBL] [Abstract][Full Text] [Related]
16. Critical Roles of NF-κB Signaling Molecules in Bone Metabolism Revealed by Genetic Mutations in Osteopetrosis.
Jimi E; Katagiri T
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887342
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K
Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600
[TBL] [Abstract][Full Text] [Related]
18. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114
[TBL] [Abstract][Full Text] [Related]
19. Constitutively active canonical NF-κB pathway induces severe bone loss in mice.
Otero JE; Chen T; Zhang K; Abu-Amer Y
PLoS One; 2012; 7(6):e38694. PubMed ID: 22685599
[TBL] [Abstract][Full Text] [Related]
20. Pilose antler peptide potentiates osteoblast differentiation and inhibits osteoclastogenesis via manipulating the NF-κB pathway.
Liu G; Ma C; Wang P; Zhang P; Qu X; Liu S; Zhai Z; Yu D; Gao J; Liang J; Dai W; Zhou L; Xia M; Yang H
Biochem Biophys Res Commun; 2017 Sep; 491(2):388-395. PubMed ID: 28733032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
